Results 251 to 260 of about 697,291 (350)

A comprehensive review on seroepidemiology and molecular epidemiology of hepatitis E Virus in Iran. [PDF]

Gastroenterol Hepatol Bed Bench
Aghapour AH, Hosseini SM, Shoraka S, Ghaemi A, Sharifian A, Mohebbi SR.   +5 more
europepmc   +1 more source

Hepatitis E (Hepatitis E virus)

, 2022
Jokelainen, Pikka, Larsen, Lars Erik, Krog, Jesper Schak, Midgley, Sofie Elisabeth, Vorobieva Solholm Jensen, Veronika   +4 more
openaire   +1 more source

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
When the acquired immunodeficiency syndrome emerged in the 1980s, the United States National Institutes of Health established research networks to conduct clinical trials with the pharmaceutical industry to identify effective antiretroviral therapeutics.
Robin DiFrancesco, Troy D. Wood, Raymond Cha, Jill S. Hochreiter, Susan L. Rosenkranz, Mona Farhad, Kyle R. Whitson, Connor E. Gould, Lauren E. Hill, Linda L. Hale, Philip H. Lindhorst, Diala Ghazal, Charlene R. Taylor, Madiha Quraishi, Suzanne M. Siminski, Yoninah Cramer, Heather L. Sprenger, Gene D. Morse   +17 more
wiley   +1 more source

Hepatitis E Virus Exposure Across Multiple Host Species in a Shared Ecosystem in Argentina. [PDF]

Vet Sci
Tammone Santos A, Rivero MA, Condorí WE, Soto TB, Moran MC, Caselli AE, Tisnés A, Uhart MM, Gutiérrez SE, Estein SM.   +9 more
europepmc   +1 more source

Hepatitis E vaccines

, 2008
Robert H. Purcell, Suzanne U. Emerson
openaire   +1 more source

Pharmacokinetic Drug–Drug Interaction Potential of Oral Anticancer Drugs

Clinical Pharmacology &Therapeutics, EarlyView.
Drug–drug interaction (DDI) management is critical for safe and effective use of oral anticancer drugs (OADs). Our study objectives were to (i) compile clinically relevant pharmacokinetic (PK) DDI mechanisms for OADs and (ii) assess the prevalence of PK potential DDIs (PDDIs) in patients with advanced solid cancers.
Fatimah Alhurayri, Islam R. Younis, Shadia I. Jalal, Theodore F. Logan, Rohan Maniar, Steven M. Bray, Sara K. Quinney, Zeruesenay Desta, Todd C. Skaar, James E. Tisdale, Tyler Shugg   +10 more
wiley   +1 more source

Meta-analysis of global prevalence of hepatitis E virus infection in deer. [PDF]

Front Microbiol
Gao ZQ, Bao GR, Wang HT, Wei YJ, Zhang M, Tan WX, Liu HL, Zhao Q, Gong QL, Jiang J, Qin Y.   +10 more
europepmc   +1 more source

The Squalene Oil‐in‐Water Nanoemulsion Vaccine Carrier AddaVax Potentiates TLR‐Induced B‐Cell Responses

Cytometry Part A, EarlyView.
ABSTRACT For vaccination, the mechanisms of action of antigens and of immunostimulatory pathogen‐associated molecular pattern (PAMP) adjuvants are better understood than the roles of the depot, carrier, and other formulation‐related influences. Here, we carried out cytometric studies of vaccine formulations and the effect of adjuvant formulations on B ...
Egest J. Pone, Jiin Felgner, Jenny Hernandez‐Davies, D. Huw Davies   +3 more
wiley   +1 more source

Molecular and serodetection of hepatitis E virus among organ donors in the Czech Republic. [PDF]

BMC Infect Dis
Slepčanová H, Glac T, Kondé A, Harazimová A, Kušnierová P.   +4 more
europepmc   +1 more source

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source